KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Prepaid Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Prepaid Assets for 15 consecutive years, with $65.3 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 81.02% to $65.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.3 million through Dec 2025, up 81.02% year-over-year, with the annual reading at $65.3 million for FY2025, 81.02% up from the prior year.
  • Prepaid Assets for Q4 2025 was $65.3 million at Supernus Pharmaceuticals, up from $62.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $65.3 million in Q4 2025, with the low at $15.8 million in Q4 2022.
  • Average Prepaid Assets over 5 years is $29.7 million, with a median of $25.9 million recorded in 2021.
  • The sharpest move saw Prepaid Assets crashed 48.25% in 2024, then soared 126.53% in 2025.
  • Over 5 years, Prepaid Assets stood at $27.0 million in 2021, then crashed by 41.6% to $15.8 million in 2022, then rose by 5.68% to $16.7 million in 2023, then surged by 116.41% to $36.1 million in 2024, then soared by 81.02% to $65.3 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $65.3 million, $62.1 million, and $31.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.